Ex Parte Kashima et al - Page 10

               Appeal 2007-1627                                                                            
               Application  09/870,009                                                                     

               portion, a non-gene portion, and a non-naturally occurring sequence                         
               embedded in the non-gene portion.  DNA is a chemical compound.  The                         
               claims’ recital of DNA comprising a gene portion and a non-gene portion                     
               indicates that the recited portions are parts of the same DNA molecule.                     
                      By contrast, the Examiner has at best established that Lizardi and                   
               Arnot disclose hybridization complexes in which a gene and a non-naturally                  
               occurring sequence are present on separate DNA molecules.  Hybridization                    
               of a probe to its genomic target does not make the probe and the genomic                    
               target parts of the same DNA molecule.  Nor does hybridizing a probe to its                 
               target “embed” the probe sequence into the target DNA, in the usual sense of                
               merging two separate molecules into a single molecule.  The probe DNA                       
               and target DNA are separate DNAs even if they are hybridized to each other                  
               under appropriate conditions.                                                               
                      “A claim is anticipated only if each and every element as set forth in               
               the claim is found, either expressly or inherently described, in a single prior             
               art reference.”  Verdegaal Bros., Inc. v. Union Oil Co., 814 F.2d 628, 631                  
               (Fed. Cir. 1987).  The Examiner has not established that Lizardi or Arnot                   
               disclose DNA comprising all of the limitations of the claims on appeal.  The                
               rejection of claims 5, 8-12, 15, 17-27, and 30-34 under 35 U.S.C. § 102(b) as               
               anticipated by Lizardi, and the rejection of claims 5, 8-11, 15, 17-27, 30, and             
               34 under 35 U.S.C. § 102(b) as anticipated by Arnot, are reversed.                          
                                               SUMMARY                                                     
                      We affirm the rejection of claims 8-10 under 35 U.S.C. § 112, second                 
               paragraph, and the rejection of claims 5, 8-12, 15, 17-27, and 30-34 under 35               



                                                    10                                                     

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next

Last modified: September 9, 2013